MedPath

Catastrophism in Chronic Inflammatory Rheumatism

Not Applicable
Completed
Conditions
Chronic Inflammatory Rheumatism
Interventions
Other: completing self-questionnaires
Registration Number
NCT04174092
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
Brief Summary

Catastrophic is defined as a negative cognitive and emotional response based on inadequate pain expression. It has three components: rumination, amplification and vulnerability. The assessment of catastrophism is carried out using a validated questionnaire called the "Pain Catatrophizing Scale" (PCS).

Recent studies highlight the significant impact of catastrophism in neuromuscular and mechanical rheumatic diseases such as gonarthrosis gonalgia and low back pain. In these diseases, it has been shown that catastrophism has a negative impact both on the experience of pain and on the response to different types of treatments (medical and surgical). Several studies have implemented multidisciplinary management and in particular cognitive-behavioural therapy with an improvement in the pain experience in patients who are catastrophic.

In chronic inflammatory rheumatic diseases such as rheumatoid arthritis, spondyloarthritis and psoriatic arthritis, the prevalence and impact of catastrophism is still poorly understood.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
533
Inclusion Criteria
  • Major patients, hospital follow-up, with RA according to ACR 2010 criteria, or spondyloarthritis according to ASAS 2009 criteria or according to AMOR or psoriatic arthritis according to Caspar 2006 criteria.
  • Patient who has given free and informed consent.
  • Patient who has signed the consent form.
  • Patient affiliated or benefiting from a health insurance plan.
  • Adult patient (≥18 years old).
Exclusion Criteria
  • Patient under the protection of justice, under guardianship or curatorship.
  • Patient unable to express consent.
  • Patient for whom it is impossible to provide informed information.
  • Poor command and understanding of the French language making it impossible to complete self-questionnaires

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
rheumatoid arthritiscompleting self-questionnairesFilling in several self-questionnaires: on function (HAQ), pain EVA, quality of life (SF12, EQ5D), anxiety score (GAD-7), insomnia score (ISI), catastrophic score (PCS), coping score (coping ability, CSQ), compliance scores (CQR, Health Insurance Compliance Assessment Questionnaire) and fibromyalgia diagnostic score (FiRST), activity of rheumatic disease (RAID, RAPID-3) Patients will be seen at 3, 6 and 12 months
spondyloarthritiscompleting self-questionnairesFilling in several self-questionnaires: on function (HAQ), pain EVA, quality of life (SF12, EQ5D), anxiety score (GAD-7), insomnia score (ISI), catastrophic score (PCS), coping score (coping ability, CSQ), compliance scores (CQR, Health Insurance Compliance Assessment Questionnaire) and fibromyalgia diagnostic score (FiRST), activity of rheumatic disease (BASDAI, BASFI). Patients will be seen at 3, 6 and 12 months
Psoriatic arthritiscompleting self-questionnairesFilling in several self-questionnaires: on function (HAQ), pain EVA, quality of life (SF12, EQ5D), anxiety score (GAD-7), insomnia score (ISI), catastrophic score (PCS), coping score (coping ability, CSQ), compliance scores (CQR, Health Insurance Compliance Assessment Questionnaire) and fibromyalgia diagnostic score (FiRST), activity of rheumatic disease (BASDAI, BASFI). Patients will be seen at 3, 6 and 12 months
Primary Outcome Measures
NameTimeMethod
catastrophic assessmentat 12 months

Pain Catastrophism Scale (0= no catastrophism, 52 = maximum catastrophism)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

CHU de Montpellier

🇫🇷

Montpellier, France

CHU de Nîmes

🇫🇷

Nîmes, France

© Copyright 2025. All Rights Reserved by MedPath